Representative before the EPO
Partner/Owner

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

We have observed 122 EP applications Hugh Goodfellow has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 18, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13741481

GENERATION OF PHOTORECEPTORS FROM HUMAN RETINAL PROGENITOR CELLS USING POLYCAPROLACTONE SUBSTRATES

IPC classification:
A61F 2/00, A01N 63/00, C12N 5/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13703243

FORMULATIONS OF 3-(6-(1-(2.2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID

IPC classification:
A61K 31/443, A61K 9/28, A61K 9/20, A61K 9/16, C07D 405/14, C07D 405/12, C07D 213/75
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13708625

PHARMACEUTICAL COMPOSITION AND ADMINISTRATION THEREOF

IPC classification:
A61K 47/38, A61K 47/32, A61K 47/26, A61K 47/02, A61K 31/47, A61K 9/16
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13755552

VARIANTS OF PROTHYMOSIN ALPHA AND METHODS OF USING SAME

IPC classification:
A61K 38/00
Agent:
Fabrizio Minoja, Bianchetti Bracco Minoja Srl
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13703505

TFPI INHIBITORS AND METHODS OF USE

IPC classification:
A61K 38/10, C07K 7/08, A61P 7/02
Applicant:
Baxalta Incorporated
Applicant:
Baxalta GmbH
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP13712101

CELL COMPOSITIONS AND METHODS OF USING SAME

IPC classification:
A61K 35/28, A61K 35/14, C12N 5/0786, C12N 5/071, A61P 9/10
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Cooley (UK) LLP
Agent:
John William Graham Jappy, Gill Jennings & Every LLP
Status:
EXAMINATION IN PROGRESS
EP13778780

HUMAN ANTIBODIES AND SPECIFIC BINDING SEQUENCES THEREOF FOR USE IN STROKE AND ISCHEMIA OR ISCHEMIC CONDITIONS

IPC classification:
A61K 39/395
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Andrew John Teuten, Sagittarius IP
Status:
The patent has been granted
EP13788302

HETEROMULTIMER CONSTRUCTS OF IMMUNOGLOBULIN HEAVY CHAINS WITH MUTATIONS IN THE FC DOMAIN

IPC classification:
A61K 39/395, C07K 16/46, C07K 16/30, C07K 16/28, C07K 16/24, C07K 16/12, A61P 37/02, A61P 35/00
Applicant:
Zymeworks Inc
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Hendrik Wichmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP13819634

ANTI-SIGLEC-15 ANTIBODIES

IPC classification:
A61K 39/395, C12N 15/85, C12N 15/13, C12N 5/10, C07K 16/28, A61P 19/08
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
William Gerrit Arends, Marks & Clerk
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13829280

METHODS AND SYSTEMS FOR SCREENING COMPOSITIONS COMPRISING NON-ANTICOAGULANT SULFATED POLYSACCHARIDES

IPC classification:
G01N 33/86, G01N 33/50, G01N 33/48
Applicant:
Baxalta Incorporated
Applicant:
Baxalta GmbH
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, Stevens Hewlett & Perkins
Status:
EXAMINATION IN PROGRESS
EP13812072

APPARATUS AND METHOD FOR BLOOD COLLECTION

IPC classification:
A61B 5/15
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13855452

DIGITAL ANALYSIS OF MOLECULAR ANALYTES USING SINGLE MOLECULE DETECTION

IPC classification:
G06F 19/00
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14740167

EVALUATION, ASSAYS AND TREATMENT OF PKAL-MEDIATED DISORDERS

IPC classification:
G01N 33/50, G01N 33/48, C12Q 1/56
Agent:
Hoffmann Eitle PartmbB
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
The patent has been granted
EP14740444

EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS

IPC classification:
C07K 16/40
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
The patent has been granted
EP14775649

METHODS OF CELL CULTURE

IPC classification:
C12N 5/07, C12N 5/00, C12P 21/04
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
The patent has been granted
EP14769180

METHODS OF CELL CULTURE

IPC classification:
A61K 39/395
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14776142

METHODS OF CELL CULTURE

IPC classification:
C12N 5/02, C12N 5/00, C12P 1/00
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14718260

METHOD OF CHARACTERIZING LYSOSOMAL ENZYMES

IPC classification:
C12N 9/24, C07K 1/26
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14721659

CD14+ CELL COMPOSITIONS AND METHODS OF USING SAME

IPC classification:
C12N 5/0775, A61P 9/10, C12N 5/071, A61K 35/28, C12N 5/0786
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Cooley (UK) LLP
Status:
EXAMINATION REQUESTED
EP15177547

CANCER THERAPIES AND PHARMACEUTICAL COMPOSITIONS USED THEREIN

IPC classification:
C07K 16/28, A61K 31/575, A61P 35/00, A61K 39/395, A61K 31/337, A61K 31/475, A61K 31/573, A61K 31/4745, A61K 31/70, A61K 31/7088, A61K 45/06
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14803492

PHARMACEUTICAL COMPOSITIONS COMPRISING PYROPHOSPHATE

IPC classification:
C01B 25/42, A61K 47/42, A61K 39/395
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14816936

TARGET ANTIGEN DISCOVERY, PHENOTYPIC SCREENS AND USE THEREOF FOR IDENTIFICATION OF TARGET CELL SPECIFIC TARGET EPITOPES

IPC classification:
C12N 15/11, G01N 33/68, G01N 33/563, G01N 33/53
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Jörk Zwicker, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
EXAMINATION REQUESTED
EP14845354

METHODS AND COMPOSITIONS FOR GENERATION OF BINDING AGENTS AGAINST CELL SURFACE ANTIGENS

IPC classification:
C12Q 1/68, G01N 33/53
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Jörk Zwicker, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
GRANT OF PATENT INTENDED
EP14849718

ANTIGEN RECEPTOR SCREENING ASSAY

IPC classification:
C07K 14/78, G01N 33/53, G01N 33/52
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Oliver Tischner, Lavoix
Status:
GRANT OF PATENT INTENDED
EP14810067

CELL SEEDING DEVICE AND METHOD

IPC classification:
C12M 1/12
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Cooley (UK) LLP
Status:
EXAMINATION REQUESTED
EP15709067

PEPTIDES AND METHODS OF USE

IPC classification:
A61K 38/00, C07K 7/08, C07K 14/745
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
EXAMINATION REQUESTED
EP15769534

COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC MACULAR EDEMA

IPC classification:
A61P 27/02, A61K 39/395, C07K 16/40
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15721094

METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY

IPC classification:
C12N 5/0783, C12N 5/0781
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15726501

SUBSTRATE-MEDIATED REACTORS FOR BIOASSAYS

IPC classification:
G01N 33/543, G01N 33/538
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16195158

TFPI INHIBITORS AND METHODS OF USE

IPC classification:
C07K 14/81, A61K 38/18
Applicant:
Baxalta Incorporated
Applicant:
Baxalta GmbH
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
EXAMINATION REQUESTED
EP15831523

MODIFIED IL-2 VARIANTS THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

IPC classification:
C07K 17/08, C07K 14/55, A61K 38/20
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP16196664

METHOD TO PREDICT AND PREVENT OXYGEN-INDUCED INFLAMMATORY TISSUE INJURY

IPC classification:
A61K 45/06, A61P 43/00, A61K 33/00, A61K 31/00, A61K 31/7076
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15759685

IODOPHOR COMPOSITION WITH IMPROVED STABILITY IN THE PRESENCE OF ORGANIC MATERIAL

IPC classification:
A23C 7/00, A61K 8/22, A61K 8/20, A61K 9/00, A61K 33/18, A01P 1/00, A01N 25/22, A01N 59/24, A01N 59/12
Applicant:
National University of Ireland, Galway (National University of Ireland Galway)
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tomkins & Co
Status:
Request for examination was made
EP17150192

CELLS ON A SUPPORT MATRIX FOR TISSUE REPAIR

IPC classification:
C12N 5/00, A61K 35/12, A61L 27/38
Applicant:
Verigen AG
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Cooley (UK) LLP
Status:
The application has been published
EP15816318

METHODS AND COMPOSITIONS FOR ADOPTIVE CELL THERAPY

IPC classification:
C07K 16/28, C07K 14/725, C07K 14/705
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15823264

ENZYMATIC ACTIVITY ASSAYS FOR GLUCOCEREBROSIDASE

IPC classification:
C12Q 1/34
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15823270

ENZYMATIC ACTIVITY ASSAYS FOR I2S

IPC classification:
C12Q 1/34
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16703392

MODIFIED HEPATITIS POST-TRANSCRIPTIONAL REGULATORY ELEMENTS

IPC classification:
C12N 15/867, C12N 15/85
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16742568

ENGINEERED CELLS FOR ADOPTIVE CELL THERAPY

IPC classification:
C12N 5/0783
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16854189

DIAGNOSIS AND TREATMENT OF PARKINSON'S DISEASE BASED ON IDENTIFICATION AND AMELIORATION OF LIVER DYSFUNCTION

IPC classification:
C12N 5/074, C12N 5/071, A61K 35/545, A61K 35/407
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16795177

MODIFICATION OF RNA-RELATED ENZYMES FOR ENHANCED PRODUCTION

IPC classification:
C12N 15/62, C12N 9/12
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16801293

METHODS FOR CULTURING CELLS AND KITS AND APPARATUS FOR SAME

IPC classification:
G01N 1/30, C12N 5/0783
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16791171

IMMUNOASSAY TO DETECT CLEAVED HIGH MOLECULAR WEIGHT KININOGEN

IPC classification:
G01N 33/86, G01N 33/68
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16810017

METHODS FOR CULTURING CELLS AND KITS AND APPARATUS FOR SAME

IPC classification:
C12N 5/00, C12N 5/0775, G01N 33/569
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16861006

COMPOSITIONS AND METHODS FOR TUMOR TRANSDUCTION

IPC classification:
C12P 21/08, C07K 16/28, C07K 16/18, A61P 35/00, A61K 45/00, A61K 39/395
Agent:
J A Kemp
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16861008

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

IPC classification:
C07K 19/00, C07K 16/28, C07K 14/705
Agent:
J A Kemp
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16810123

CHIMERIC RECEPTORS CONTAINING TRAF-INDUCING DOMAINS AND RELATED COMPOSITIONS AND METHODS

IPC classification:
C07K 14/705, C07K 14/00, A61K 35/17, A61K 39/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16862739

CELL CYCLE BLOCK IMPROVES EFFICIENCY IN GENERATING INDUCED PLURIPOTENT STEM CELLS

IPC classification:
C12N 5/071, A61K 35/35, A61K 35/12, A61K 35/545
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16865056

PLATELET BIOMARKERS AND DIAGNOSTIC METHODS FOR VASCULAR DISEASES

IPC classification:
G01N 33/53, G01N 33/50, G01N 1/40, C12N 5/078, C07K 16/18, C07K 14/47, A61P 7/02
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16856265

METHODS AND COMPOSITIONS FOR THE TREATMENT OF EPIDERMOLYSIS BULLOSA

IPC classification:
A61P 17/02, A61K 31/415, A61K 38/12, A61K 38/08
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16810158

RECOMBINANT HUMAN C1 ESTERASE INHIBITOR AND USES THEREOF

IPC classification:
C07K 14/81, A61K 38/57
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16829013

MODIFIED CHIMERIC RECEPTORS AND RELATED COMPOSITIONS AND METHODS

IPC classification:
C07K 14/705
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16802111

TRANSDUCTION BUFFER

IPC classification:
A61K 31/205, C12N 15/87, A61K 47/02, A61K 47/26, A61K 47/18, A61K 47/10
Applicant:
Royal Netherlands Academy of Arts and Sciences (Koninklijke Nederlandse Akademie van Wetenschappen (KNAW))
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16822844

PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING HEREDITARY ANGIOEDEMA ATTACK

IPC classification:
A61K 39/395, A61K 39/00, C07K 16/40
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18154983

ANTI-PSGL-1 ANTIBODIES AND METHODS OF IDENTIFICATION AND USE

IPC classification:
C07K 16/28, C12P 21/08
Agent:
HGF Limited
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18170703

COMPOSITIONS FOR TREATING STOMACHAL AND OESOPHAGEAL CANCER CELLS

IPC classification:
G01N 33/574, C12N 15/113, C12Q 1/6886, C07K 16/30, A61K 31/7048, A61K 51/10, A61K 9/127, A61K 31/7034, C07H 21/04, C12P 19/34, C12Q 1/68
Applicant:
Thomas Jefferson University
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16825947

PEPTIDE QUANTITATION ASSAY FOR DIFFERENTIATING FULL-LENGTH HIGH MOLECULAR WEIGHT KININOGEN (HMWK) AND CLEAVED HMWK

IPC classification:
G01N 33/68, C07K 14/81
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16822558

METHODS AND COMPOSITIONS RELATED TO TOXICITY ASSOCIATED WITH CELL THERAPY

IPC classification:
G01N 33/68
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16876662

METHODS OF TREATING EXACERBATED INFLAMMATORY RESPONSE WITH TOPOISOMERASE l INHIBITORS

IPC classification:
A61P 35/00, A61K 38/06
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16826889

2H-CHROMENO[2,3-D]PYRIMIDINE-2,4(3H)-DIONES AS NF-KB INHIBITORS

IPC classification:
A61P 35/00, A61P 37/00, A61P 29/00, A61K 31/519, C07D 495/04, C07D 491/052
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18169049

GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES

IPC classification:
A61K 35/12, G01N 33/50, C12N 5/0783, C07K 16/28, C07K 14/735, A61K 35/17, A61K 49/00, A61K 39/395, C07K 16/32, C12N 5/00, C07K 14/705
Agent:
Elkington and Fife LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17703599

ANTI-C5 ANTIBODIES WITH ENHANCED PH SWITCH

IPC classification:
C07K 16/40, C07K 16/18
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18175999

RESORPTION ENHANCERS AS ADDITIVES TO IMPROVE THE ORAL FORMULATION OF NON-ANTICOAGULANT SULFATED POLYSACCHARIDES

IPC classification:
A61P 1/00, A61K 9/10, A61K 9/08, A61K 31/726, A61K 38/17, A61K 31/715, A61K 31/737
Applicant:
Baxalta Incorporated
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP17708395

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A

IPC classification:
A61P 3/00, A61K 38/46
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17753896

NASAL BIOMARKERS OF ASTHMA

IPC classification:
C40B 40/08, G01N 33/48, C12Q 1/68
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18173405

ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES

IPC classification:
A61K 39/00, C07K 16/24
Applicant:
Janssen Biotech, Inc.
Applicant:
Eli Lilly and Company Limited
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP17708234

IMPROVED DIFFERENTIATION METHOD

IPC classification:
C12N 5/071
Applicant:
Royal Netherlands Academy of Arts and Sciences (Koninklijke Nederlandse Akademie van Wetenschappen (KNAW))
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17714977

METHODS FOR ADAPTIVE DESIGN OF A TREATMENT REGIMEN AND RELATED TREATMENTS

IPC classification:
G06F 19/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18185299

MRNA THERAPEUTIC COMPOSITIONS AND USE TO TREAT DISEASES AND DISORDERS

IPC classification:
C12N 15/88, A61K 48/00, C12N 15/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP17714976

METHODS FOR DETERMINING DOSING OF A THERAPEUTIC AGENT AND RELATED TREATMENTS

IPC classification:
G06F 19/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17771260

HSV VECTORS FOR DELIVERY OF NT3 AND TREATMENT OF CIPN

IPC classification:
A61P 25/28, A61P 25/00, A61K 48/00, A61K 39/245, A61K 38/18, A61K 38/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17719044

EARLY INTERVENTION METHODS TO PREVENT OR AMELIORATE TOXICITY

IPC classification:
A61K 39/00, C07K 16/28
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17771265

HIGH-TRANSDUCING HSV VECTORS

IPC classification:
A61K 39/245, A61K 39/395, A61K 38/17
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18184740

METHODS AND MATERIALS FOR CANINE BREED IDENTIFICATION

IPC classification:
G06F 19/18, G01N 33/50, G01N 33/48, C12Q 1/6888, C12Q 1/68
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18193801

PURIFICATION OF IDURONATE-2-SULFATASE

IPC classification:
A61K 38/17, C07K 16/00, C07K 1/00
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17723271

ADENOVIRAL VECTORS

IPC classification:
C07K 14/005, C12N 15/86
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17719409

CONJUGATED C1 ESTERASE INHIBITOR AND USES THEREOF

IPC classification:
A61K 47/61, A61K 47/60
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17721899

MULTIMERIC CODING NUCLEIC ACID AND USES THEREOF

IPC classification:
C12N 15/11, C07H 21/02, A61K 31/7125, A61K 31/7115, C12N 15/09
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17783333

USE OF IL-22 IN TREATING NECROTIZING ENTEROCOLITIS

IPC classification:
C07K 14/54, A61P 1/00, A61K 38/20
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18199421

BISPECIFIC EGFR/C-MET ANTIBODIES

IPC classification:
A61P 35/00, C07K 16/28, A61K 33/24, A61K 31/5377, A61K 31/437, A61K 45/06, A61K 31/517, A61K 31/4545, A61K 39/395, C07K 16/00
Applicant:
Janssen Biotech, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18201321

MRNA THERAPY FOR TREATMENT OF OCULAR DISEASES

IPC classification:
A61K 48/00, C12P 21/06, C12N 15/02
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Examination is in progress
EP18185286

CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES

IPC classification:
A61K 31/7105, A61K 47/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17793538

SYNAPTIC PROTEIN BIOMARKERS AND DIFFERENTIAL DIAGNOSIS OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS

IPC classification:
G01N 33/68, G01N 33/53
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18185359

ONCOSTATIN M RECEPTOR ANTIGEN BINDING PROTEINS

IPC classification:
C07K 16/28
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP18188349

POLYPEPTIDES WITH ENHANCED ANTI-INFLAMMATORY AND DECREASED CYTOTOXIC PROPERTIES AND RELATING METHODS

IPC classification:
C12P 21/08, C07K 16/18, C07K 16/00, A61K 39/395
Applicant:
The Rockefeller University
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP18186356

EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS

IPC classification:
G01N 33/50, C07K 16/40
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP18185298

PLASMA KALLIKREIN BINDING PROTEINS

IPC classification:
C07K 16/40, C07K 16/18, A61K 39/395
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17727829

ANTI-PAD4 AUTOANTIBODIES AS CLINICAL RESPONSE BIOMARKERS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

IPC classification:
A61K 39/00, G01N 33/68, A61K 49/00, C07K 16/28
Applicant:
MedImmune Limited
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18205176

METHODS FOR PURIFICATION OF MESSENGER RNA

IPC classification:
C12N 15/10
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP18208603

TREATMENT OF PKAL-MEDIATED DISORDERS

IPC classification:
C12Q 1/56, G01N 33/50, G01N 33/48
Agent:
Hoffmann Eitle PartmbB
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP17732860

IMPROVED DIFFERENTIATION METHOD

IPC classification:
A61K 31/4427, C12N 5/071
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17740170

MHC-E RESTRICTED EPITOPES, BINDING MOLECULES AND RELATED METHODS AND USES

IPC classification:
C12N 5/0783, C07K 17/00, C07K 4/00, G01N 33/566, G01N 33/68
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17740520

METHOD OF IDENTIFYING PEPTIDE EPITOPES, MOLECULES THAT BIND SUCH EPITOPES AND RELATED USES

IPC classification:
G01N 33/68, C12N 15/869, C12N 15/10, C12Q 1/68
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17734898

MESSENGER RNA THERAPY FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY

IPC classification:
A61K 48/00, C12N 9/10
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18197990

EGFR AND C-MET-FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES

IPC classification:
A61K 45/06, C07K 16/28, A61K 39/395, A61P 35/00, C07K 14/78, A61K 38/00, A61K 38/39
Applicant:
Janssen Biotech, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP17754530

METHODS FOR ASSESSING THE PRESENCE OR ABSENCE OF REPLICATION COMPETENT VIRUS

IPC classification:
C12Q 1/70
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17754228

BIOREACTOR CONSOLE

IPC classification:
C12M 3/06, C12M 3/00, C12M 1/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17752521

IMMUNOMODULATORY POLYPEPTIDES AND RELATED COMPOSITIONS AND METHODS

IPC classification:
C07K 14/725, C07K 14/71, C07K 14/705, C07K 14/575, C07K 14/61, C07K 14/535, C07K 14/54, C07K 14/52, A61K 38/19
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18205998

METHODS OF TREATING ANTIBODY-MEDIATED REJECTION IN ORGAN TRANSPLANT PATIENTS WITH C1-ESTERASE INHIBITOR

IPC classification:
A61P 37/00, A61K 39/395, A61K 35/16, A61K 38/55
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP18206005

ANTI-IL23 ANTIBODIES, COMPOSITIONS, METHODS AND USES

IPC classification:
A61P 37/00, C07K 16/24, C12P 21/06, C07H 21/04, G01N 33/567, A61K 39/395
Applicant:
Janssen Biotech, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP18205194

MRNA THERAPY FOR ARGININOSUCCINATE SYNTHETASE DEFICIENCY

IPC classification:
A61K 31/7105, A61K 48/00, A61K 9/127, A61P 3/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP17768886

METHODS OF ENUMERATING PARTICLES PRESENT IN A CELL COMPOSITION

IPC classification:
C12N 5/00, G01N 33/543
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17844754

ALLOSTERIC SPLIT TREHALASE BIOSENSOR

IPC classification:
G01N 33/53, G01N 27/403, G01N 21/75, C12Q 1/34, C12Q 1/26, C12M 1/34, C12Q 1/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18206413

C1-INH COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICENCY

IPC classification:
A61K 47/12, A61K 9/00, A61K 38/17, A61K 47/18, A61K 47/02, A61K 38/57, A61K 38/16, C07K 14/81, A61K 38/55, A61K 38/48, A61P 31/00, A61P 5/00, A61K 38/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP17772206

PERFUSION BIOREACTOR BAG ASSEMBLIES

IPC classification:
C12M 3/06, C12M 1/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17784716

RNA BIOMARKERS FOR HEREDITARY ANGIOEDEMA

IPC classification:
C12Q 1/68, G01N 33/50
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17777136

PROTEIN BIOMARKERS FOR DISEASES ASSOCIATED WITH THE CONTACT ACTIVATION SYSTEM

IPC classification:
G01N 33/68
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17777137

METABOLITE BIOMARKERS FOR DISEASES ASSOCIATED WITH THE CONTACT ACTIVATION SYSTEM

IPC classification:
G01N 33/68
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17787729

HPV-SPECIFIC BINDING MOLECULES

IPC classification:
C07K 14/725
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17861545

METHOD OF PREDICTING GRAFT VERSUS HOST DISEASE

IPC classification:
G01N 33/68, C12Q 1/68, A61K 35/28
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17847798

COMBINATION THERAPY OF A CELL BASED THERAPY AND A MICROGLIA INHIBITOR

IPC classification:
A61P 35/00, A61K 31/444, A61K 39/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18210289

FIBRONECTIN TYOE III REPEAT BASED PROTEIN SCAFFOLDS WITH ALTERNATIVE BINDING SURFACES

IPC classification:
C40B 40/10, C40B 50/00
Applicant:
Janssen Biotech, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP17809103

SUBCUTANEOUS DELIVERY OF MESSENGER RNA

IPC classification:
A61P 3/00, A61K 38/45
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17804762

IMPROVED ICE-BASED LIPID NANOPARTICLE FORMULATION FOR DELIVERY OF MRNA

IPC classification:
A61K 48/00, A61K 9/127, A61K 47/28, A61K 9/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17818338

IMPROVED PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES

IPC classification:
A61K 48/00, A61K 47/28, A61K 47/22, A61K 9/127
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17872725

QUANTIFICATION OF SUBPOPULATIONS OF EXOSOMES AND DIAGNOSIS OF NEURODEGENERATIVE DISORDERS

IPC classification:
C12N 5/22, G01N 33/531, G01N 33/53, G01N 33/483
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17825663

METHODS FOR DETERMINING CAR-T CELLS DOSING

IPC classification:
A61K 39/00, A61K 39/44, A61K 39/395
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17825665

PRODUCTION OF ENGINEERED CELLS FOR ADOPTIVE CELL THERAPY

IPC classification:
C07K 14/47, C07K 14/705, C07K 14/725, C12N 15/867, A61K 35/17, C12N 5/0783
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17823256

ENGINEERED B CELLS AND RELATED COMPOSITIONS AND METHODS

IPC classification:
C12N 15/66
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP17825318

METHODS FOR MODULATION OF CAR-T CELLS

IPC classification:
A61K 39/44, A61K 39/395
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP19167639

LIVER ORGANOID, USES THEREOF AND CULTURE METHOD FOR OBTAINING THEM

IPC classification:
C12N 5/071, C12N 5/074
Applicant:
Royal Netherlands Academy of Arts and Sciences (Koninklijke Nederlandse Akademie van Wetenschappen (KNAW))
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP19160013

MESSENGER RNA BASED VIRAL PRODUCTION

IPC classification:
A61K 48/00, C12N 15/86
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published

Please Sign in to use this feature